Fundraising Fox

Nrxpharma

Wilmington, US · Founded 2017 · 1 known investors

nrxpharma.com ↗

NRx Pharmaceuticals is a clinical-stage pharmaceutical company developing NRX-101, an investigational drug in FDA trials for suicidal bipolar depression that has received fast track and breakthrough therapy designations. Through its subsidiary HOPE Therapeutics, the company also works on neuroplastic therapies and treatments for depression, including efforts to prevent veteran suicide.

BiotechDigital HealthMental Healthin /nrx-pharma@NRxPharma

Founders & leadership

MA
Michael AbramsExecutive Officer
KB
Kim BennettChief Investment Officer
MF
Michael FongDirector
RA
Richard AckermanChairman, President and Chief Executive Officer
LB
Lori B. WittmanChief Financial Officer and Director
TT
Troy T. TaylorDirector
SF
Stuart F. KoenigDirector
AG
Albert G. RexDirector
RB
Richard BardoffDirector
JJ
Jonathan JavittFounder, Chairman & CEO
CH
Chaim HurvitzDirector
PF
Patrick FlynnDirector

Investors · 1

Kinled HoldingHong Kongvia Patrick Aisher · inferred

Reported raises · per SEC filings

Form D private placements
▶$3.5MraisedMar 2025 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Patrick FlynnDirector
  • Michael AbramsExecutive Officer
  • Michael TaylorDirector
  • Jonathan JavittExecutive Officer, Director
  • Chaim HurvitzDirector
  • Dennis McBrideDirector
Offering amount
$3.5M
Amount sold
$3.5M
Sales commissions
$245K
Placement agents
D. Boral Capital
First sale
Jan 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedNov 2017 · 1 investors · Commercial
Rule 506(b)
Officers, directors & promoters on the filing
  • Kim BennettExecutive Officer
  • Michael FongDirector
  • Richard AckermanExecutive Officer, Director
  • Lori B. WittmanExecutive Officer, Director
  • Troy T. TaylorDirector
  • Stuart F. KoenigDirector
  • Albert G. RexDirector
  • Richard BardoffDirector
Offering amount
$2.8M
Amount sold
$2.5M
Minimum investment
$25K
First sale
Sep 2017
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.